Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 20/20 | 0.65 |
| ▸ | KCNH2 | Q12809 | 11/20 | 0.65 |
| ▸ | CTSD | P07339 | 1/20 | 0.64 |
| ▸ | CTSE | P14091 | 1/20 | 0.64 |
| ▸ | BACE2 | Q9Y5Z0 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2015085 | 1.00 | BACE1 (0.65) | BACE1KCNH2CTSDCTSEBACE2 | |
| SCHEMBL1998808 | 0.93 | BACE1 (0.67) | BACE1KCNH2CTSDCTSEBACE2 | |
| SCHEMBL2381576 | 0.93 | BACE1 (0.67) | BACE1KCNH2CTSDCTSEBACE2 | |
| SCHEMBL15510003 | 0.92 | BACE1 (0.66) | BACE1KCNH2CTSDCTSEBACE2 | |
| SCHEMBL15509944 | 0.91 | BACE1 (0.65) | BACE1KCNH2CTSDCTSEBACE2 | |
| SCHEMBL15510053 | 0.86 | BACE1 (0.72) | BACE1KCNH2CTSDCTSEBACE2 | |
| SCHEMBL6845306 | 0.83 | BACE1 (0.75) | BACE1KCNH2CTSDCTSEBACE2 | |
| SCHEMBL15510542 | 0.83 | BACE1 (0.77) | BACE1KCNH2CTSDCTSEBACE2 | |
| SCHEMBL1992842 | 0.83 | BACE1 (0.77) | BACE1KCNH2CTSDCTSEBACE2 | |
| SCHEMBL1992843 | 0.83 | BACE1 (0.77) | BACE1KCNH2CTSDCTSEBACE2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2328903-A1 | SPIRO-TETRACYCLIC RING COMPOUNDS AS BETASECRETASE MODULATORS AND METHODS OF USE | Amgen Inc. (US) | 2011-06-08 | — | — | EP | disclosed |
| WO-2010030954-A1 | SPIRO-TETRACYCLIC RING COMPOUNDS AS BETASECRETASE MODULATORS AND METHODS OF USE | AMGEN INC. (US) | 2010-03-18 | — | — | WO | disclosed |